USA Today: Lawmakers push legislation to protect doctors who prescribe ivermectin for COVID-19
UC legal expert weighs in on move
USA Today reports that at least 26 states have proposed or passed legislation that would increase patient access to the invermectin, a drug some individuals have asked to be used to treat COVID-19, though its effectiveness remains under debate.
Many of the legislative bills who protect physicians who prescribe ivermectin for COVID-19 against disciplinary action from state medical boards and hospitals.
According to the U.S. Food Drug and Administration website, the agency FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea, according to the FDA..
Jennifer Bard, PhD
The Federation of State Medical Boards has opposed any legislation intended to limit a state board’s ability to protect patients, but legal experts says states do have the final authority on who can practice medicine and how. Jennifer Bard, PhD, professor in UC’s Colleges of Law and Medicine, shared her thoughts.
“Health and safety is within the states’ power unless the federal government uses authority … to step in,” said Bard, who was quoted by USA Today. “States are doing what they can do within their authority to remove whatever concerns physicians might have prescribing these drugs.”
Making invermectin available over-the-counter may, however be a step too far for the authority of legislators. “There’s an internal process for the FDA to change the label,” Bard told USA Today. “The FDA could make something over-the-counter, but only they can do that.”
Read the full USA Today story online.
Featured photo courtesy of Unsplash.
Related Stories
192nd Hooding ceremony at UC Law to recognize Class of 2025
Event: May 17, 2025 1:00 PM
The University of Cincinnati College of Law celebrates its graduates, alumni at the 192nd Hooding Ceremony.
Hoxworth Co-Director David Oh, MD, named to America's Blood...
May 14, 2025
Hoxworth Blood Center, University of Cincinnati, is proud to announce that David Oh, MD, interim co-director and chief medical officer, has been appointed to America’s Blood Centers (ABC) Board of Directors.
Osher Center, Cancer Center partnership receives $2 million gift...
May 14, 2025
The Cincinnati Business Courier highlighted a $2 million gift from John and Carrie Hayden to establish and endow a community learning kitchen that emphasizes the vital role of nutrition not only in the prevention but also the treatment of chronic disease.